Welcome to PharmaLive's Digital Download Library, a free resource where you can access The Med Ad News Show Podcast series as well as White Papers compiled from trusted industry leaders and encompassing a variety of topics relevant to the pharmaceutical, medical devices, and biotech industries. You can view the most recent additions to our library below or browse by topic in our category listings to the right.
 |
Aberdeen Research Report: Sales Mobility
Provided by: Aberdeen Research
The past two years brought a wave of iPad purchases for reps, but left many life science companies asking “Now what?” While “shiny object syndrome” compels many to experiment and adopt these technologies, r...
|
 |
Managed Markets Contract Effectiveness: Optimizing Rebates and Relationships
Provided by: SAS Institute Inc.
Managed markets contracts continue to be exposed to dynamic changes, from unprecedented government mandates to evolving market forces. And with $40 billion in rebates and discounts on the line, pharmaceutical compan...
|
 |
Achieving Excellence in Marketing Operations: Three Essential Capabilities for Life Sciences Companies that Want to Execute Prec
Provided by: SAS Institute Inc.
Marketing tends to be one of the least efficient processes in business today, while, at the same time, being one of the most important differentiators. This white paper talks about three key software solutions vital...
|
 |
Analytics in Managed Markets: Negotiate Like a Pro
Provided by: SAS Institute Inc.
This white paper reveals why analytics is the secret ingredient to achieving success in managed markets and explains why new legislation and other market factors have increased the risks of continuing business as us...
|
 |
THE MED AD NEWS SHOW Episode 15: Certifying compliance
Provided by: Med Ad News magazine
In Episode 15 of The Med Ad News Show, Managing Editor Joshua Slatko is joined by Ilyssa Levins and Wayne Pines of the Center for Communications Compliance and Scott Cotherman, CEO, CAHG, the first healthcare advert...
|
 |
Vodafone mHealth Solutions Insights Guide - Evaluating mHealth Adoption Barriers: Human Behaviour
Provided by: Vodafone
With input from a series of industry specialists, this Insights Guide from Vodafone mHealth Solutions delivers insights into the role that patients and healthcare professionals play in the acceptance of new mHealth ...
|
 |
PHARMALOT PODCAST: Patients are thought leaders too
Provided by: Pharmalot
Brian Loew is the founder and CEO of Inspire, a Website that builds online patient communities. In this Pharmalot podcast, Mr. Loew discusses the evolving social media landscape, opportunities to engage patients thr...
|
 |
Viable Protein Expression for Global Pharmaceutical Company
Provided by: Ajinomoto's Corynex
Ajinomoto's Corynex Recombinant Protein Expression System is a novel protein expression system able to produce http://www.corynex.com/video-load.aspx complex pro...
|
 |
THE MED AD NEWS SHOW Episode 14: BIO's big ideas
Provided by: Med Ad News magazine
In Episode 14 of The Med Ad News Show, James C. Greenwood, CEO and president of BIO, continues his conversation with Editors Steve Niles and Joshua Slatko to discuss the results of the organization's recent survey o...
|
 |
THE MED AD NEWS SHOW Episode 13: The government and drug development
Provided by: Med Ad News magazine
In Episode 13 of The Med Ad News Show, Editors Steve Niles and Joshua Slatko are joined by Biotechnology Industry Organization President and CEO James C. Greenwood to discuss President Obama's FY 2012 budget proposa...
|
 |
THE MED AD NEWS SHOW Episode 12: Politics, approvals, and PhRMA's future
Provided by: Med Ad News magazine
In the final installment of a two-part series, Med Ad News Show hosts Steve Niles and Joshua Slatko are joined by John Castellani, the new President and CEO of the Pharmaceutical Research and Manufacturers of Americ...
|
 |
THE MED AD NEWS SHOW Episode 11: Meet your new president
Provided by: Med Ad News magazine
John Castellani became President and CEO of the Pharmaceutical Research and Manufacturers of America in August 2010. Six months into his tenure, Mr. Castellani sits down with Steve Niles and Joshua Slatko, the hosts...
|
 |
Pharmerging markets insights
Provided by: IMS Health
As growth opportunities continue to dwindle in more developed markets, pursuing the emerging markets is a strategic priority for multi-national pharmaceutical companies. In a special Podcast presentation released in...
|
 |
PHARMALOT PODCAST: Flawed Data Puts Formulary Placement at Risk part 2
Provided by: Pharmalot
Good formulary placement is a critical factor in getting drug products prescribed, but flawed clinical trial data may be putting those placements in jeopardy. In part 2 of this two-part series, Ed Silverman spoke wi...
|
 |
PHARMALOT PODCAST: Flawed Data Puts Formulary Placement at Risk
Provided by: Pharmalot
Good formulary placement is a critical factor in getting drug products prescribed, but flawed clinical trial data may be putting those placements in jeopardy. In the premier episode of the Pharmalot Podcast series, ...
|
 |
THE MED AD NEWS SHOW Episode 10: Not all interests are conflicts
Provided by: Med Ad News magazine
Episode 10 of The Med Ad News Show Podcast concludes the three-part series of conversations with Thomas Sullivan, the president and founder of Rockpointe Corporation and the creator of the Policy and Medicine blog a...
|
 |
THE MED AD NEWS SHOW Episode 9: Reform factor
Provided by: Med Ad News Magazine
Episode 9 of The Med Ad News Show Podcast continues the three-part series of conversations with Thomas Sullivan, the president and founder of Rockpointe Corporation and the creator of the Policy and Medicine blog at...
|
 |
Best Practices to Ensure Successful Sponsor and CRO Pharmacovigilance Alliances
Provided by: PRA International
Outsourcing pharmacovigilance activities is a standard business practice in a rapidly expanding market segment. When outsourcing services the best relationships between sponsors and contractors are those that are we...
|
 |
THE MED AD NEWS SHOW Episode 8: Defender of industry-sponsored CME
Provided by: Med Ad News magazine
For decades, continuing medical education has been under attack, faced with charges of bias and conflict of interest when sponsored by commercial organizations. Episode 8 of The Med Ad News Show Podcast kicks off a ...
|
 |
Pharma S&M Offshoring: The Next Level
Provided by: Indegene
Save. Impact. Innovate
It is an open secret that the Global Pharmaceutical Industry's Sales and Marketing model is under tremendous pressure. The spate of layoffs, re-organizations and growth in outsourci...
|
 |
Human ADME & Studies with Radiolabeled Compounds
Provided by: PRA International
During clinical drug development there can be several situations where the use of radiolabeled medication or other compounds is required or favorable to accomplish the study objectives. This whitepaper is mainly foc...
|
 |
THE MED AD NEWS SHOW Episode 7: Apply the squeeze, measure the juice
Provided by: Med Ad News magazine
Pharmaceutical sales forces throughout the industry are adopting closed-loop marketing (CLM) programs to gain real-time physician feedback from their product details. But effectively measuring and analyzing the floo...
|
 |
THE MED AD NEWS SHOW Episode 6: The promise of CLM
Provided by: Med Ad News magazine
Closed-loop marketing (CLM) technology allows sales representatives to collect continuous, real-time feedback to create targeted marketing messages. In Episode 6 of The Med Ad News Show Podcast, Dale Hagemeyer, a ma...
|
 |
A New Approach to Outsourced Drug Development: How Sponsor-CRO Clinical Delivery Alliances Improve Performance
Provided by: INC Research
As sponsor companies struggle to replace the revenue loss threatened by generics, they are searching for more cost-effective ways to increase the number of drugs in their development pipeline.
Many of them are ...
|
 |
THE MED AD NEWS SHOW Episode 5: The Silver Lining
Provided by: Med Ad News magazine
A silver lining may exist for the healthcare communications industry. John Kamp, executive director of the Coalition for Healthcare Communication, discusses why communications companies could see an upswing in busin...
|
 |
THE MED AD NEWS SHOW Episode 4: Approach With Caution
Provided by: Med Ad News magazine
Following the FDA hearing on the pharmaceutical industry use of social media, marketers are moving forward cautiously. John Kamp, executive director of the Coalition for Healthcare Communication, talks about why leg...
|
 |
Favorable Regulatory Procedures in the Netherlands
Provided by: PRA International
The Netherlands offers pharmaceutical firms a favorable environment for receiving expedited study review. Clinical studies can be rapidly initiated in The Netherlands due to Dutch government regulations for clinical...
|
 |
THE MED AD NEWS SHOW Episode 3: Don't Forget FDAAA
Provided by: Med Ad News magazine
John Kamp, executive director of the Coalition for Healthcare Communication, discusses what is yet to come from the Food and Drug Administration Amendments Act of 2007, including the growing importance of Risk Evalu...
|
 |
THE MED AD NEWS SHOW Episode 2: The New FDA
Provided by: Med Ad News magazine
A new FDA is in charge under Commissioner Margaret Hamburg and Deputy Commissioner Joshua Sharfstein. John Kamp, executive director of the Coalition for Healthcare Communication, discusses why he has confidence in t...
|
 |
THE MED AD NEWS SHOW Episode 1: Tax Terror
Provided by: Med Ad News magazine
Industry narrowly avoided an elimination of the marketing expense tax exemption in the healthcare reform bill. However, it's a popular idea in Washington that could rear its head again with potentially devastating e...
|
 |
Renal Impairment Studies in Early Development
Provided by: PRA International
Renal impairment trials are typically included as part of the clinical development of a drug. This whitepaper, based on years of experience executing renal trials, provides practical information for pharma ...
|
 |
Hepatic Impairment Studies in Early Development
Provided by: PRA International
Hepatic impairment trials are generally included as part of the clinical development of a drug. This whitepap...
|
